Literature DB >> 3061076

The mechanism of discordant xenograft rejection.

S Miyagawa1, H Hirose, R Shirakura, Y Naka, S Nakata, Y Kawashima, T Seya, M Matsumoto, A Uenaka, H Kitamura.   

Abstract

The mechanism of discordant xenograft rejection using the guinea pig-to-rat heart graft model was studied. In this model, we found that (A) Rejection occurred rapidly, in 17.5 +/- 8.3 min (mean +/- SD) (n = 8). (B) The graft survived longer when the recipient rat was pretreated with cobra venom facter (CVF). (C) Complement hemolytic titers in serum showed significant reduction of C3 in rejection without consumption of C4 and C2, suggesting complement activation through the alternative pathway. (D) No natural antibodies were detected in this combination. Complement-dependent cytotoxicity (CDC) titer, and hemagglutination (HA) titer were lower than x1. (E) Histological examination of the rejected heart xenograft revealed a large area of myocytolysis without interstitial cellular infiltration. (F) In vitro experiments showed that rat complement attacked guinea pig erythrocytes (Egp) via the alternative pathway. These findings indicate that rejection in this discordant xenograft model of guinea pig-to-rat was caused by primary activation of complement via the alternative pathway.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3061076     DOI: 10.1097/00007890-198812000-00007

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  23 in total

1.  The possible use of HLA-G1 and G3 in the inhibition of NK cell-mediated swine endothelial cell lysis.

Authors:  K Matsunami; S Miyagawa; R Nakai; A Murase; R Shirakura
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

2.  Immunofluorescent localization of pig complement component 3, regardless of the presence or absence of detectable immunoglobulins, in hyperacutely rejected heart xenografts.

Authors:  M W Wang; P S Johnston; L J Wright; S M Lim; D J White
Journal:  Histochem J       Date:  1992-02

3.  Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1.

Authors:  T Seya; M Okada; T Hara; M Matsumoto; S Miyagawa; M Oshimura
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

Review 4.  Recent advances in the immunology of xenotransplantation.

Authors:  T Takahashi; S Saadi; J L Platt
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

5.  Immune complex formation after xenotransplantation : evidence of type III as well as type II immune reactions provide clues to pathophysiology.

Authors:  Z E Holzknecht; S Coombes; B A Blocher; T B Plummer; M Bustos; C L Lau; R D Davis; J L Platt
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

6.  Trial using pig cells with the H-D antigen knocked down.

Authors:  Aki Yamamoto; Kosuke Ikeda; Dandan Wang; Shino Nakatsu; Yuichi Takama; Takehisa Ueno; Hiroshi Nagashima; Akihiro Kondo; Masahiro Fukuzawa; Shuji Miyagawa
Journal:  Surg Today       Date:  2012-08-05       Impact factor: 2.549

7.  Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity.

Authors:  N A Begum; Y Murakami; S Mikata; M Matsumoto; M Hatanaka; S Nagasawa; T Kinoshita; T Seya
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

8.  Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients.

Authors:  A P Dalmasso; G M Vercellotti; R J Fischel; R M Bolman; F H Bach; J L Platt
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

Review 9.  The role of antibodies in transplantation.

Authors:  Alexander T Chang; Jeffrey L Platt
Journal:  Transplant Rev (Orlando)       Date:  2009-07-22       Impact factor: 3.943

10.  Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope.

Authors:  Saema Magre; Yasuhiro Takeuchi; Gillian Langford; Andrew Richards; Clive Patience; Robin Weiss
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.